1Franciosi JP,Tam V,Liacouras CA,et al.A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis.Clin Gastroenterol Hepatol,2009,7:415-419.
2Croese J,Fairley SK,Masson JW,et al.Clinical and endoscopic features of eosinophilic esophagitis in adults.Gastrointest Endosc,2003,58:516-522.
3Potter JW,Saeian K,Staff D,et al.Eosinophilie esophagitis in adults:an emerging problem with unique esophageal features.Gastrointest Endosc,2004,59:355-361.
4Parfitt JR,Gregor JC,Suskin NG,et al.Eosinophilic esophagitis in adults:distinguishing features from gastroesophageal reflux disease:a study of 41 patients.Mod Pathol,2006,19:90-96.
5Sgouros SN,Bergele C,Mantides A.Eosinophilic esophagitis in adults:what is the clinical significance? Endoscopy,2006,38:515-520.
7Noel RJ,Sampson HA.Epidemiology and etiology of Eos-inophilie esophagitis.N Engl J Med,2004,251:940-941.
8Almansa C,Krishna M,Buchner AM,et al.Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults.Am J Gastroenterol,2009,104:828-833.
9Prasad GA,Alexander JA,Schleck CD,et al.Epidemiology of eosinophilic esophagitis over three decades in Olmsted County,Minnesota.Clin Gastroenterol Hepatol,2009,7:1055-1061.
5Liacouras CA,Furuta GT,Hirano I,et al.Eosinophilic esophagitis:updated consensus recommendations for children and adults[J].J Allergy Clin Immunol,2011,128 (1):3-20.e6.
6Spergel JM,Brown-Whitehorn TF,Beausoleil JL,et al.14 years of eosinophilic esophagitis:clinical features and prognosis[J].J Pediatr Gastroenterol Nutr,2009,48(1):30-36.
7Abdulnour-Nakhoul SM,A1-Tawil Y,Gyftopoulos AA,et al.Alterations in junctional proteins,inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis[J].Clin Immunol,2013,148 (2):265-278.
8Wu Y,Zhang X,Zehner ZE.c-Jun and the dominantnegative mutant,TAM67,induce vimentin gene expression by interacting with the activator Sp1[J].Oncogene,2003,22 (55):8891-8901.
9Wu Y,Diab I,Zhang X,et al.Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein,ZBP-89[J].Oncogene,2004,23 (1):168-178.
10Fryer AD,Stein LH,Nie Z,et al.Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction[J].J Clin Invest,2006,116(1):228-236.
